Weekly Recap | INNOVENT BIO -6.57%, most brokers rate it buyWeekly Review·Oct 24, 2026 at 05:12 AM01801+7.18%
Weekly Recap | INNOVENT BIO -3.31%, most brokers rate it buyWeekly Review·Oct 17, 2026 at 05:33 AM01801+7.18%
Weekly Recap | INNOVENT BIO -4.78%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 05:15 AM01801+7.18%
Weekly Recap | INNOVENT BIO +0.1%, consensus target above spotWeekly Review·Oct 3, 2026 at 05:20 AM01801+7.18%
